![iurtc-logo2](http://blogs.iu.edu/innovate/files//2016/06/iurtc-logo2.jpg)
Arrhythmotech LLC, which was launched through the Spin Up program at Indiana University Research and Technology Corp., has received a two-year STTR Phase II grant worth $1,472,476 from the National Institutes of Health.
Dr. Peng-Sheng Chen, company co-founder, said the grant will be used on new methods to study patients who are affected by atrial fibrillation.
![Peng-Sheng Chen](https://blogs.iu.edu/iuimpact/files/2016/07/Peng-Sheng-Chen-150x150.jpg)
“The grant will allow us to collaborate with investigators at the Mayo Clinic in Rochester, Minnesota, and at Cedars-Sinai Medical Center in Los Angeles,” he said.
More information about the NIH grant and how Arrhythmotech will benefit is here.
Leave a Reply